Saltar al contenido
Merck
  • 2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.

2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.

Natural product reports (2012-11-28)
Sung Ryeol Park, Je Won Park, Yeon Hee Ban, Jae Kyung Sohng, Yeo Joon Yoon
RESUMEN

The 2-deoxystreptamine-containing aminoglycosides, such as neomycin, kanamycin and gentamicin, are an important class of antibiotics. A detailed understanding of the complete biosynthetic pathway of aminoglycosides and their biosynthetic enzymes will allow us to not only generate more robust antibiotic agents or drugs with other altered biological activities, but also to produce clinically important semi-synthetic antibiotics by direct fermentation. This Highlight focuses on recent advances in the characterization of their biosynthetic enzymes and pathway as well as some chemo-enzymatic and metabolic engineering approaches for the biological production of natural, semi-synthetic, and novel aminoglycosides.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder, BioReagent, suitable for cell culture
Supelco
Neomycin trisulfate salt hydrate, VETRANAL®, analytical standard
Sigma-Aldrich
Neomycin trisulfate salt hydrate, meets USP testing specifications, powder
Sigma-Aldrich
Neomycin trisulfate salt hydrate, suitable for plant cell culture
Neomycin sulphate, European Pharmacopoeia (EP) Reference Standard